| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| TP53 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
| TP53 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
| TP53 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: Decitabine; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
| TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#45 |
Permissive
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
| TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #45 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
| TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #45 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
| TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#90 |
Permissive
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
| TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #90 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
| TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #90 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
| TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#104 |
Permissive
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
Showing 10 records in page 8
from 18 pages